ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

MCRB Seres Therapeutics Inc

1.15
0.04 (3.60%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Seres Therapeutics Inc MCRB 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.04 3.60% 1.15 08:56:13
개장가 저가 고가 종가 전일 종가
1.11 1.08 1.19 1.16 1.11
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/04/202420:00BWSeres Therapeutics Announces Completion of Patient..
28/03/202420:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
19/03/202420:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
06/03/202400:18EDGAR2Form DEF 14A - Other definitive proxy statements
06/03/202400:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/03/202421:05EDGAR2Form 8-K - Current report
05/03/202421:00BWSeres Therapeutics Reports Fourth Quarter and Full Year 2023..
05/03/202420:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
28/02/202421:00BWSeres Therapeutics to Host Fourth Quarter 2023 Financial..
27/02/202421:00BWSeres Therapeutics to Participate in Cowen 44th Annual..
26/02/202421:06EDGAR2Form 8-K - Current report
26/02/202421:00BWSeres Therapeutics Announces the Appointment of Marella..
24/02/202406:05EDGAR2Form PRE 14A - Other preliminary proxy statements
17/02/202411:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202411:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202411:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202411:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202411:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/01/202406:01EDGAR2Form 8-K - Current report
17/01/202421:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
10/01/202421:00EDGAR2Form 8-K - Current report
09/01/202422:10DJNSeres Therapeutics Shares Rise 15% After Getting FDA..
09/01/202421:05EDGAR2Form 8-K - Current report
09/01/202421:00BWSeres Therapeutics Announces VOWST™ Commercial Launch Update..
05/01/202406:00BWSeres Therapeutics to Participate in the 42nd Annual J.P...
03/01/202406:05EDGAR2Form 8-K - Current report
08/12/202309:46BWSeres Therapeutics Announces Presentation of Preliminary..
28/11/202323:18BWSeres Therapeutics to Participate in the Piper Sandler 35th..
28/11/202309:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202320:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
02/11/202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202320:05EDGAR2Form 8-K - Current report
02/11/202320:00BWSeres Therapeutics Reports Third Quarter 2023 Financial..
01/11/202323:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
01/11/202310:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202310:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202310:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202310:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202310:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202310:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202306:30BWSeres Therapeutics to Announce Third Quarter 2023 Results on..
12/10/202320:00BW Seres Therapeutics to Highlight VOWST™ Data at IDWeek
06/10/202320:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
04/10/202320:00EDGAR2Form 8-K - Current report
11/09/202319:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
08/09/202320:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
07/09/202323:00BWSeres Therapeutics to Participate in the Morgan Stanley 21st..
29/08/202322:00PRNUSInvaio achieves first registration for citrus greening..
16/08/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
09/08/202305:07EDGAR2Form S-3 - Registration statement under Securities Act of..

최근 히스토리

Delayed Upgrade Clock